CoSara Diagnostics Private Limited

Our global partners include Asence Inc, a U.S. incorporated company specializing in supplying pharmaceutical products to international markets. CODX has a Joint Venture agreement for manufacturing with Synbiotics Ltd, a group company of Asence Inc.

CoSara has the exclusive manufacturing rights in India for the complete menu of Co-Diagnostics infectious disease molecular diagnostics kits, engineered using Co-Diagnostics’ proprietary design process and patented CoPrimer™ technology. CoSara was incorporated in 2017, and its 2,500 sq ft Good Manufacturing Practices (GMP) facility is one of the first of its kind in India for manufacturing in vitro diagnostics designated for clinical use.

The JV facility in Ranoli, India was inaugurated in April 2019 to manufacture CODX-designed products under the label CoSara Diagnostics, Pvt., Ltd according to internationally-recognized Current Good Manufacturing Practices (“cGMP”) standards. In December 2019, CoSara received approval by the Central Drug Standard Control Organization (“CDSCO”) for the following in vitro diagnostics:

  • Mycobacterium tuberculosis
  • Malaria
  • Hepatitis B
  • Hepatitis C
  • Human papillomavirus (HPV)

The website for CoSara Diagnostics may be found here: